Category Archives: Z Medical centers

Does President Trump have “heart disease” based on his Coronary Calcium Score?

Posted on October 7, 2018 by admin

January 20, 2018- by Steven E. Greer, MD President Trump made news this week by having his doctor, Admiral Ronny Jackson, MD, answer

Posted in - NEJM, - Opinion, - Policy, Cardiac surgery, Cardiology, CDC, Emory, Internal Medicine, Neurosurgery, NIH | Leave a comment

KIT inhibition by Gleevec (imatinib) for severe asthma

Posted on September 1, 2018 by admin

May 26, 2017- Interviewed by Steven E. Greer, MD Novartis’ Gleevec (imatinib) was approved in the U.S. in 2001 to treat leukemia. Now, researchers

Posted in - Biotech, - NEJM, - Pharma, National Jewish Health, Pulmonology | Leave a comment

Antoni Ribas, MD discusses cancer drugs targeting the PD1 signaling pathways

Posted on September 1, 2018 by admin

March 19, 2013- Interviewed by Steven E. Greer, MD The upcoming ASCO meeting will be dominated by numerous presentations relating to new

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

The Gluten Crazies are out of control and affecting menus in restaurants

Posted on March 2, 2018 by admin

April 26, 2015- By Steven E. Greer, MD I was eating at a French restaurant recently, and the waiter asked me if I had any allergies, such as “gluten”.

Posted in - Opinion, Gastroenterology and liver, Harvard, Pediatrics | Leave a comment

Bending the cost curve of cancer care

Posted on February 26, 2018 by admin

May 25, 2011- Since the approval of Genentech’s costly Avastin in 2004, prominent oncologists have warned that

Posted in - Biotech, - Pharma, CMS, Oncology, VCU | Leave a comment

Did Hillary Clinton really faint from “dehydration” or does she have a chronic neurological condition?

Posted on February 24, 2018 by admin

September 12, 2016- by Steven E. Greer, MD Once again, the Hillary Clinton campaign is on defense after another health scare from their

Posted in - Policy, Cardiology, Congress, Emergency medicine, Neurology, NYU, Ophthalmology, Primary care medicine, Radiology | Leave a comment

Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer (FLAURA)

Posted on February 23, 2018 by admin

November 20, 2017- Interviewed by Steven E. Greer, MD We interviewed Emory University oncologist Suresh S. Ramalingam, M.D. about his NEJM

Posted in - NEJM, Cardiac surgery, Emory, Oncology | Leave a comment

Hormone replacement therapy is safe and effective after all

Posted on January 31, 2018 by admin

November 14, 2017- Interviewed by Steven E. Greer, MD We interviewed JoAnn Manson, MD, DrPH about her JAMA paper that followed the cohorts in

Posted in - JAMA, Cardiology, Diabetes and endocrinology, FDA, Geriatrics, Harvard, Obstetrics and Gynecology, Oncology, Orthopedic surgery, Primary care medicine | Leave a comment

CT-scan screening for heart disease fails to show benefit

Posted on January 5, 2018 by admin

March 23, 2015- Interviewed by Steven E. Greer, MD We interviewed the Principal Investigator of the PROMISE trial, Pamela Douglas, MD from Duke.

Posted in - NEJM, - Policy, Cardiology, CMS, Duke, Radiology | Leave a comment

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

Posted on January 4, 2018 by admin

May 23, 2017- interviewed by Steven E. Greer, MD We interviewed polumonologist Michael Wechsler, MD about his paper in the NEJM testing mepolizumab

Posted in - NEJM, National Jewish Health, Pulmonology, Rheumatology | Leave a comment

Maybe my brain was spared

Posted on January 4, 2018 by admin

July 26, 2017- by Steven E. Greer, MD Last week, I sat next to an Ohio State University offensive lineman while attending a Roger Waters

Posted in - JAMA, - Reviews, books, devices, Neurology, Neurosurgery, Ohio State | Leave a comment

Vagal nerve stimulation for weight loss

Posted on January 2, 2018 by admin

January 22, 2015- Interviewed by Steven E. Greer, MD Erik Dutson, MD, bariatric surgeon from UCLA, discusses the newly FDA-approved weight loss device called

Posted in - Medical Devices, Bariatric surgery, Diabetes and endocrinology, Gastroenterology and liver, Primary care medicine, UCLA | Leave a comment

Review of combination immunotherapies seen at ASCO 2016

Posted on January 2, 2018 by admin

June 22, 2016- interviewed by Steven E. Greer, MD We interviewed Siwen Hu-Lieskovan MD, PhD of UCLA, an expert with immunotherapies for melanoma,

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

The 23andMe home genetics test kit controversy

Posted on November 26, 2017 by admin

December 19, 2013- Interviewed by Steven E. Greer,  MD

Posted in Columbia, FDA, Genetics, NIH, Oncology, Psychology Psychiatry | Leave a comment

The bionic pancreas data

Posted on November 18, 2017 by admin

July 2, 2014- Interviewed by Steven E. Greer, MD The New England Journal of Medicine recently published the early clinical data on the “bionic pancreas”

Posted in - Medical Devices, - NEJM, Boston University, Diabetes and endocrinology | Leave a comment

Changes in plastic surgery training programs

Posted on November 17, 2017 by admin

March 3, 2015- Interviewed by Steven E. Greer, MD In Part 1 of our interview with the new Chairman of Plastic Surgery at NYU, Eduardo Rodriguez,

Posted in - Policy, NYU, Plastic surgery | Leave a comment

Aerobic or Resistance Exercise, or Both, in Dieting Obese Older Adults

Posted on November 8, 2017 by admin

June 14, 2017- Interviewed by Steven E. Greer, MD We interviewed Dennis Villareal, MD, the author of the NEJM paper “Aerobic or Resistance

Posted in - NEJM, Bariatric surgery, Baylor, Diabetes and endocrinology, Geriatrics, Internal Medicine | Leave a comment

The egregious athletic coaching most kids receive

Posted on November 5, 2017 by admin

March 25, 2016- by Steven E. Greer, MD In 2005, at age 37, I got some good PGA golf lessons at Muirfield Golf Club in Ohio: Jack Nicklaus’

Posted in - Opinion, - Reviews, books, devices, Ohio State, Sports medicine | Leave a comment

CheckMate 026: Why did Opdivo (nivolumab) fail in NSCLC?

Posted on September 9, 2017 by admin

September 1, 2016- Interviewed by Steven E. Greer, MD In the wake of the news-making failure of CheckMate 026 of Bristol-Myers Squibb’s Opdivo (nivolumab) fail in

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

The ACA’s THC program: A pilot program to fund residency training outside of the traditional hospital setting

Posted on September 1, 2017 by admin

September 6, 2016- Interviewed by Steven E. Greer, MD

Posted in - NEJM, - Policy, CMS, George Washington Univ | Leave a comment